LondonOnly 3 of 84 Parkinson’s trials combined drugs.
Parkinson’s is driven by multiple disease pathways at once, so single-target drugs have repeatedly failed to slow it, researchers said.
Cure Parkinson’s will use the workshop’s findings to guide future combination-therapy funding calls.
Sources: Nature